The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study

Table 3 Univariate and multivariate analyses of in-hospital outcomes

	Univariate analysis			Multivariate analysis
	OR	95% C.I	P	OR	95% C.I	P
All-cause death
log NT-proBNP	3.06	1.77–5.28	< 0.001	2.86	1.16–7.03	0.022
Anaemia	9.43	2.05–43.27	0.004	4.63	0.49–43.41	0.179
Chronic heart failure	3.14	0.99–10.01	0.053	0.88	0.20–3.93	0.865
Chronic kidney disease	3.98	1.25–12.64	0.019	1.96	0.33–11.5	0.458
NSTEMI	3.15	0.99–10.01	0.051	3.07	0.56–16.90	0.198
LVEF	0.96	0.92–1.00	0.037	1.00	0.95–1.05	0.990
Age	1.04	0.98–1.11	0.170	2.86	1.16–7.03	0.436
MACE
log NT-proBNP	1.98	1.47–2.68	< 0.001	2.09	1.35–3.23	0.001
Anaemia	2.72	1.15–6.42	0.023	1.09	0.37–3.18	0.875
Chronic heart failure	1.28	0.47–3.51	0.633	0.39	0.11–1.36	0.139
Chronic kidney disease	2.86	1.23–6.68	0.015	1.73	0.58–5.19	0.326
NSTEMI	1.27	0.53–3.07	0.589	0.74	0.26–2.11	0.571
LVEF	0.98	0.95–1.01	0.130	1.01	0.97–1.05	0.617
Age	1.04	0.99–1.08	0.096	1.00	0.95–1.05	0.940
Diabetes	1.41	0.60–3.30	0.425	0.92	0.34–2.51	0.868
Myocardial infarction	1.64	0.63–4.25	0.308	0.81	0.25–2.70	0.736
Operation time 24–72 h (Reference is 24 h)	0.93	0.33–2.62	0.884	0.82	0.23–2.90	0.758
Operation time > 72 h (Reference is 24 h)	1.46	0.54–3.98	0.456	1.62	0.52–5.03	0.406

NT-proBNP N-terminal pro-B-type natriuretic peptide, NSTEMI non–ST-segment elevation myocardial infarction, LVEF left ventricular ejection fraction, MACE major adverse cardiovascular events

ISSN: 1471-2261